Oct 10 |
GSK Posts New Data From Phase III Study on RSV Vaccine Arexvy
|
Oct 9 |
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
|
Oct 8 |
Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to Note
|
Oct 7 |
Low RSV and COVID vaccine usage is in line with investor expectations, but concerning: Jefferies
|
Oct 6 |
Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio?
|
Oct 5 |
Jim Cramer Reports That Moderna, Inc. (MRNA) Was ‘Down Nearly 44% In The Third Quarter’
|
Oct 5 |
Wall Street Breakfast: What Moved Markets
|
Oct 3 |
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
|
Oct 3 |
Eli Lilly, Moderna and more: The 5 highest paid healthcare CEOs
|
Oct 2 |
Abbas Hussain Joins Moderna's Board of Directors
|